PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21074994-0 2011 Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models. 2,3,4,5-tetrahydro-benzo[d]azepine 6-40 anaplastic lymphoma kinase Mus musculus 113-116 21074994-1 2011 The synthesis and biological evaluation of potent and selective anaplastic lymphoma kinase (ALK) inhibitors from a novel class of 2,4-diaminopyrimidines, incorporating 2,3,4,5-tetrahydro-benzo[d]azepine fragments, is described. 2,3,4,5-tetrahydro-benzo[d]azepine 168-202 anaplastic lymphoma kinase Mus musculus 64-90 21074994-1 2011 The synthesis and biological evaluation of potent and selective anaplastic lymphoma kinase (ALK) inhibitors from a novel class of 2,4-diaminopyrimidines, incorporating 2,3,4,5-tetrahydro-benzo[d]azepine fragments, is described. 2,3,4,5-tetrahydro-benzo[d]azepine 168-202 anaplastic lymphoma kinase Mus musculus 92-95